相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Solving the dilemma of EEG misinterpretation
John W. Miller et al.
NEUROLOGY (2013)
The socioeconomic consequences of multiple sclerosis: A controlled national study
Pout Jennum et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2012)
Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis
Aaron E. Miller et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Long-term follow-up of a phase 2 study of oral teriflunomide in relapsing multiple sclerosis: safety and efficacy results up to 8.5 years
Christian Confavreux et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Teriflunomide Increases the Proportion of Patients Free from Disease Activity in the TEMSO Phase III Study (PD5.007)
M. Freedman et al.
NEUROLOGY (2012)
Teriflunomide added to interferon-β in relapsing multiple sclerosis A randomized phase II trial
M. S. Freedman et al.
NEUROLOGY (2012)
Teriflunomide for oral therapy in multiple sclerosis
Athina Papadopoulou et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2012)
Pathophysiology of multiple sclerosis and the place of teriflunomide
R. Gold et al.
ACTA NEUROLOGICA SCANDINAVICA (2011)
Multiple Sclerosis: Pathogenesis and Treatment
Ingrid Loma et al.
CURRENT NEUROPHARMACOLOGY (2011)
Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis
Gavin Giovannoni et al.
LANCET NEUROLOGY (2011)
Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
Paul O'Connor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Socioeconomic Trends in Hospitalization for Multiple Sclerosis
Shivanand P. Lad et al.
NEUROEPIDEMIOLOGY (2010)
A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
Gavin Giovannoni et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
Ludwig Kappos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Economic Burden of Multiple Sclerosis A Systematic Review of the Literature
Huseyin Naci et al.
PHARMACOECONOMICS (2010)
Teriflunomide reduces behavioral, electrophysiological, and histopathological deficits in the Dark Agouti rat model of experimental autoimmune encephalomyelitis
Jean E. Merrill et al.
JOURNAL OF NEUROLOGY (2009)
Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study
Eva Havrdova et al.
LANCET NEUROLOGY (2009)
A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses
PW O'Connor et al.
NEUROLOGY (2006)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
WI McDonald et al.
ANNALS OF NEUROLOGY (2001)
分享论文
